Incubation of UV-irradiated plasmid DNA with a protein extract prepared from Escherichia coli cells led to the production of mutations in the cro gene residing on the plasmid. The mutations were detected in a subsequent bioassay step, which involved transformation of an indicator strain with the plasmid DNA that was retrieved from the reaction mixture, followed by plating on lactose/MacConkey plates. UV mutations produced in this cell-free reaction required the recA and umuC gene products and were prevented by rifampicin, an inhibitor of RNA polymerase, which inhibited plasmid replication. Removal of pyrimidine photodimers from the plasmid by enzymatic photoreactivation after the in vitro stage, but prior to transformation, increased plasmid survival as expected. Surprisingly, it also caused a large increase in the frequency of UV mutations detected in the bioassay. This photoreactivation-stimulated in vitro UV mutagenesis was dependent on the excision repair genes uvrA, uvrB, and uvrC and occurred in the absence of DNA replication. This suggests that two distinct UV mutagenesis pathways occurred in vitro: a replication-dependent pathway (type I) and a repair-dependent pathway (type II). DNA sequence analysis of type II UV mutations revealed a spectrum similar to that of in vivo UV mutagenesis. When the photoreactivation step was included in the protocol, type II UV mutagenesis did not require the RecA and UmuC proteins. These results are in agreement with the in vivo delayed photoreactivation phenomenon, where the removal ofphotodimers after an incubation period eliminated the requirement for RecA and UmuC in UV mutagenesis. The above system will enable the biochemical analysis of UV mutagenesis and the isolation of proteins involved in the process.
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UV mutagenesis in Escherichia coli is an active process that requires the involvement of a specific set of proteins, occurs at a defined time span, and is manifested as a specific spectrum of DNA sequence alterations (1, 2) . It is believed that UV mutagenesis occurs opposite a UV lesion located in a segment of single-stranded DNA (1, 3) . Such a premutagenic site can be generated by interruption of DNA replication at the lesion or by excision repair of closely opposed UV lesions, where the removal of a UV lesion from one strand results in a single-stranded DNA excision gap containing the second UV lesion. Which of these mechanisms accounts for UV mutagenesis is an unsettled issue. On the basis of the kinetics of fixation of UV mutations, it was suggested that in wild-type (wt) cells UV mutagenesis occurs primarily at excision repair gaps, whereas in excision repair-deficient cells, mutations arise at replication forks that were stalled by UV damage (3) (4) (5) .
The key step in UV mutagenesis is thought to be a trans-lesion DNA synthesis reaction (also termed bypass synthesis), which converts the single-stranded DNA segment carrying the UV lesion into duplex form. According to this model, the reaction is carried out by a specialized form of DNA polymerase that has the capability of polymerizing through UV lesions (1, 3, 6, 7) . The nature of this DNA polymerase is not clear, but it is likely to be derived from DNA polymerase III and may be assisted by SOS-inducible proteins. This suggestion is supported by the dependence of UV mutagenesis on the SOS-controlled genes recA (8, 9) , umuD, and umuC (10, 11) and on the a subunit of DNA polymerase III holoenzyme (12) (13) (14) (15) , the major replicative polymerase in E. coli (16) . The bypass synthesis step is likely to be similar in the two pathways of UV mutagenesis since in both wt and uvr mutants UV mutagenesis shows the same genetic dependence on recA, umuC, and umuD. It has been proposed that UV mutagenesis involves two distinct steps: misincorporation, in which a nucleotide is polymerized opposite the lesion in a recA-and umuD/C-independent reaction, and extension past the lesion, which requires the RecA and UmuD/C proteins (17, 18) .
In an attempt to elucidate the molecular mechanism of UV mutagenesis, we have developed an assay system based on a cell-free UV mutagenesis reaction coupled to a bioassay. Using this system, we present evidence for the existence of both replication-dependent and repair-dependent pathways of UV mutagenesis. Incorporation of the radiolabeled dNTP into the acidinsoluble material was determined as described (26) .
MATERIALS AND METHODS

Materials
The cro Mutagenesis Bioassay. After completion of the in vitro reaction, the mixtures were heat inactivated for 10 min at 65°C, and the DNA was purified as follows: the proteins were digested by proteinase K treatment (final concentration of 0.4 mg/ml, 1 hr at 37°C), after which the samples were extracted with phenol and precipitated with ethanol. RNA originating from the protein extract was digested with RNase A, followed by another phenol extraction and ethanol precipitation. After this purification, whenever desired, photodimers were eliminated from the DNA by enzymatic photoreactivation (EPR) by using E. coli DNA photolyase (a generous gift from A. Sancar, University of North Carolina) as described (29) . Samples containing -150 ng of the purified DNA were used to transform the WBM535 indicator strain, using the Ca/Mops method (30) . The cells were plated on lactose/MacConkey indicator plates containing kanamycin at 50 ,ug/ml, and colonies were scored after an incubation period of 20 hr at 37°C.
RESULTS
The cro Bioassay System. In the system described below, UV mutations were generated during the incubation of a pBR322-derived plasmid carrying the cro gene of bacteriophage A with a protein extract from E. coli cells. Mutations in cro were detected in a subsequent bioassay step, which involved the introduction of the plasmid into the appropriate indicator strain, followed by plating and screening, which allowed the phenotypic detection of mutant colonies. The cro mutagenesis assay system is described in detail elsewhere (31) . Briefly, the indicator strain WBM535 carries a A(lacpro) chromosomal mutation, a A imm2l prophage that contains a single copy of the lacZ gene under the control of the ORPR operator/promoter of bacteriophage A, and a ArecA mutation that renders the cell nonmutable by UV light. In cells harboring the cro gene on a plasmid, expression of the chromosomal lacZ gene is repressed by the Cro repressor, leading to the inability of the cells to ferment lactose. Thus, transformation ofthe indicator strain with a cro plasmid leads to the appearance of white colonies on lactose/MacConkey indicator plates. When an indicator cell is transformed by a plasmid that carries a mutation in cro that sufficiently reduces the amount of repressor or its binding to the operator, OR, lacZ is expressed, thereby allowing lactose fermentation and leading to the appearance of red colonies on the indicator plates. The plasmid used was pOC2, a pBR322 derivative that carries the cro gene along with the bla and kan genes encoding resistance to ampicillin and kanamycin, respectively.
The bioassay consisted of the transformation of competent E. coli WBM535 cells with plasmid pOC2, followed by plating on lactose/MacConkey plates containing kanamycin. Transformation efficiency for nonirradiated CsCl-purified plasmid was typically 2-5 x 106 transformants per jig of DNA. It decreased 2-, 4-, and 8-fold for plasmids irradiated at 100, 200, and 400 JPm-2, respectively, due to inactivation of the plasmid by UV radiation. Thus, the transformation efficiency of a UV-irradiated plasmid represents its UV survival. The mutation frequency was calculated by dividing the number of red colonies (cells harboring plasmid with a mutated cro gene) by the overall number of transformants. Usually several hundred thousand transformants were obtained for each plasmid sample. Each in vitro UV mutagenesis experiment was performed three or four times, and the results were averaged. The deviation between experiments was +40% when performed without EPR and +20-30% in experiments that included EPR, where larger numbers of mutants were obtained (see below). The basal mutation frequency for a nonirradiated CsCl-purified plasmid pOC2 was 2.0 x 10-5 per transformant. This mutation frequency remained essentially unchanged for plasmids that had been UV irradiated with a dose of up to 400 J-m-2, as expected for a ArecA strain (Fig.  1) . Thus the indicator strain itself cannot produce mutations in the UV-irradiated plasmid.
The in Vitro UV Mutagenesis Reaction. The reaction conditions that were employed are based on the in vitro repli- (32) . Under these conditions, between 500 and 800 pmol of nucleotides was incorporated into the DNA when 900 pmol (as nucleotides) of substrate nonirradiated plasmid DNA was used. This DNA synthesis originated almost exclusively (95%) from DNA replication, which was semi-conservative, and had the characteristics of in vivo pBR322 replication: it was unidirectional; it started from the pBR322 origin of replication; and it depended on RNA polymerase, DNA polymerase I, and DNA polymerase III holoenzyme (unpublished results). The extent of DNA synthesis decreased to 40%, 20%, and 10%o when using pOC2 DNA irradiated at 100, 200, and 400 Jm-2, respectively, which was most likely due to termination at UV lesions (33, 
34).
After incubation, the plasmid was isolated from the reaction mixture and assayed for the presence of mutations in cro as described above. As can be seen in Fig. 1 and in Fig. 2A , incubation of the plasmid with protein extracts from two different wt cells (TK701 and IT1870, respectively) led to a 5-to 10-fold increase in the frequency of cro mutations in a UV dose-dependent manner. Remarkably, the in vitro replication ofnonirradiated plasmid had no effect on the frequency of cro mutations, indicating that the fidelity of DNA replication in the extract was as high as the in vivo replication.
The addition of rifampicin, an inhibitor of RNA polymerase, to the reaction mixture prevented the production of UV mutations ( Fig. 2A) . Since replication of pOC2 is rifampicin sensitive (data not shown), these results suggest that UV mutagenesis requires DNA replication, or else it involves another rifampicin-sensitive step.
UV Mutagenesis Requires the recA and umuC Gene Products. To examine the involvement of the recA and umuDIC gene products in the cell-free UV mutagenesis reaction, we have used fraction II from mutant strains deficient or mutated in these proteins. As shown in Fig. 2A , UV mutations increased up to 10-fold for a plasmid irradiated at 400 J.m-2 when incubated with an extract from a wt strain (IT1870). Essentially no UV mutations were produced when the plasmids were incubated with a protein extract prepared from an isogenic ArecA derivative (EST1779) (Fig. 2A) . The level of DNA synthesis in the two extracts was similar (data not shown), implying that the difference in mutagenesis did not Similar experiments were carried out with protein extracts obtained from strains TK701 (wt) and TK702 (umuC36). As shown in Fig. 2B , UV mutagenesis was reduced, but not completely eliminated, when assayed with extracts prepared from the umuC36 strain. The residual UV mutagenesis observed could have resulted from residual activity of the mutated UmuC protein in the extract, or else it may represent a umuC-independent branch of UV mutagenesis. Such pathways were shown to exist for UV mutagenesis of phage S13 (21) and the F episome (35) . Thus, in vitro UV mutagenesis requires the RecA and UmuC proteins, similar to the in vivo situation.
Photoreactivation of the DNA Prior to TrandormationStimulated in Vitro UV Mutagenesis. UV-irradiated plasmid DNA retrieved from the in vitro reaction mixture still contained UV lesions. Although the indicator strain could not generate UV mutations due to its recA deficiency, we were concerned that there might have been some processing of UV lesions into mutations in the indicator strain. In an attempt to clarify this point, we have eliminated the photodimers from the plasmid by EPR with purified E. coli DNA photolyase (29) . This was done after incubation with the protein extract and prior to transformation. As expected, due to the elimination of inactivating photodimers, the EPR increased plasmid survival up to that of nonirradiated DNA (data not shown). Surprisingly, the EPR also caused a 20-30-fold increase in the frequency of UV mutations as a function ofthe UV dose, from 2 x 10-5 with nonirradiated DNA up to x 10-5 with DNA originally irradiated at 400 J-m-2 (Fig. 3) .
UV-irradiated DNA that did not undergo the in vitro reaction but was photoreactivated showed the background mutation frequency of 2 x 10-5. This result indicates that UV mutations were indeed produced during the in vitro reaction but were not efficiently detected in the absence of EPR, possibly due to the low survival of plasmids carrying a relatively high number of photodimers. As will be described below, these mutations may represent a pathway of UV mutagenesis (type II UV mutagenesis) different from the rifampicin-sensitive pathway observed in the absence of EPR (type I UV mutagenesis).
The EPR treatment leaves minor UV lesions in the DNA, such as 64 pyrimidine adducts (36) ArecA indicator strain that we have constructed was transformed with UV-irradiated plasmid pOC2, both with or without an EPR treatment prior to transformation, no UV mutations were observed in cro (data not shown). This rules out the possibility that the indicator strain can process nonphotoreactivatable UV lesions into mutations. Photoreactivation-Stimulated in Vitro UV Mutagenesis Does Not Depend on DNA Replication and Requires the uvr Gene Products. The addition of rifampicin to the in vitro reaction mixture had no effect on EPR-stimulated in vitro UV mutagenesis (Fig. 3) , indicating that unlike type I UV mutagenesis, type II UV mutagenesis did not depend on DNA replication. When the assay was performed with extracts prepared from a uvrA strain, EPR-stimulated UV mutagenesis was greatly reduced (Fig. 4A) . The same was found with extracts prepared from a uvrB or a uvrC strain (Fig. 4A) . Thus, the pathway stimulated by EPR was dependent on the excision repair genes and did not depend on DNA replication. These biochemical characteristics define it as a separate pathway, termed type II UV mutagenesis. The residual UV mutagenesis observed with the uvr extracts (Fig. 4A ) is likely to be of the type I.
Photoreactivation-Stimulated in Vitro UV Mutagenesis Does Not Depend on the recA and umuC Gene Products. EPRstimulated UV mutagenesis remained essentially unaffected when the reaction was performed with extracts prepared from cells carrying a TnS insertion in the umuC gene or a ArecA mutation (Fig. 4B) . Thus, with EPR included in the protocol, type II UV mutagenesis was not dependent on the recA and umuC gene products. Since this pathway could be assayed only when the photoreactivation step was included, we do not know at this point whether it depends on RecA and UmuC in the absence of photoreactivation.
The Spectrum of EPR-Stimulated in Vitro UV Mutagenesis Is Similar to in Vivo UV Mutations. To determine the spectrum of in vitro-produced type II UV mutations, mutant plasmids (from red colonies) obtained from in vitro mutagenesis experiments carried out with fraction II from wt cells were isolated, and the identity of the mutations produced in cro was determined by DNA sequence analysis. Table 1 presents a total of42 mutants: 28 UV mutations that were distributed among 14 sites and 14 background mutations that were distributed among 6 sites. Nearly 80to ofthe UV mutations were transitions, mostly G&C -> A-T transitions. In contrast, most of the back- (3, (38) (39) (40) . Removal of one of the UV lesions by the uvr system is expected to leave a short excision gap in the DNA containing the second UV lesion, a structure that cannot be repaired by excision repair. The filling-in of such an excision gap is likely to result in a mutation due to misincorporation opposite the UV lesion.
There is evidence to support a similar excision repairdependent mechanism for UV mutagenesis in yeast (41) (42) (43) .
The fact that photoreactivation did not eliminate the mutations argues that the mutagenic step, most likely misincorporation of a dNMP residue opposite a UV lesion, was completed in the test tube prior to transformation. The lack ofdependence of this step on the umuC and recA gene products suggests that they act in a separate later step, which is needed to complete the mutagenic process but is not associated with the actual production of the mutation. This later step, which was circumvented by EPR, occurs inefficiently in the test tube, most likely due to insufficient quantities of proteins such as UmuD/C in the extract. This finding is similar to the delayed photoreactivation phenomenon described by Bridges and Woodgate (17) . They have found that photoreactivation, after an incubation period, of UV-irradiated E. coli cells released UV mutations from their dependence on the recA and umuC gene products.
In the experiments described here, the protein extracts were prepared from noninduced cells. This implies that the constitutive level of SOS-controlled proteins in these extracts was sufficiently high to promote the mutagenic reaction. Under these conditions, type II photoreactivation-stimulated UV mutations were produced much more efficiently than type I mutations (Fig. 3) . This does not necessarily reflect their relative efficiency in vivo. Rather, it is likely to be primarily the result of circumventing the requirement for UmuD/C proteins by the EPR treatment. We anticipate that protein extracts prepared from SOS-induced cells will be more effective in carrying out type I UV mutagenesis.
Despite a considerable research effort, the molecular mechanism of UV mutagenesis is unknown. The availability of the assay system described above, in which UV mutations are produced efficiently in the test tube, will hopefully facilitate the biochemical dissection of UV mutagenesis and enable the elucidation of its molecular mechanism.
